AstraZeneca/Oxford

Company

UK-based collaboration developing a replication-defective simian adenovirus vaccine for COVID-19, which experienced clinical holds due to neurological issues.

Mentioned in 1 video

Videos Mentioning AstraZeneca/Oxford

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

Peter Attia MD

UK-based collaboration developing a replication-defective simian adenovirus vaccine for COVID-19, which experienced clinical holds due to neurological issues.